Dietary interventions for AMD: What do we know and what do we not know?

British Journal of Ophthalmology

Volumn 97, Issue 9, 2013, Pages 1089-1090

  Evans, Jennifer R ^a   Lawrenson, John G ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b CITY UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASBESTOS; BETA CAROTENE; OMEGA 3 FATTY ACID; PLACEBO; XANTHOPHYLL; ZEAXANTHIN;

CANCER RISK; COCHRANE LIBRARY; DIET SUPPLEMENTATION; EATING HABIT; EDITORIAL; ENVIRONMENTAL EXPOSURE; EVIDENCE BASED MEDICINE; FOOD COMPOSITION; HEART FAILURE; HUMAN; LIFESTYLE; LUNG CANCER; METHODOLOGY; MORTALITY; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA MACULA AGE RELATED DEGENERATION; SMOKING; SYSTEMATIC ERROR; VITAMIN SUPPLEMENTATION;

DEGENERATION; MACULA;

ANTIOXIDANTS; DIETARY SUPPLEMENTS; HUMANS; MACULAR DEGENERATION; MINERALS; REVIEW LITERATURE AS TOPIC; VITAMINS;

EID: 84882246956     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2013-303134     Document Type: Editorial

References (10)

1. Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database Syst Rev 2012(6):CD000253.
2. Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev 2012(11):CD000254.
3. Lawrenson JG, Evans Jr. Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev 2012(11):CD010015.
4. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6.
5. Age-Related Eye Disease Study Research G. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001;119:1417-36.
6. Beatty S, Chakravarthy U, Nolan JM, et al. Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration. Ophthalmology 2012. Published Online First: Epub Date. doi:10.1016/j.ophtha.2012.08.040
7. Omenn GS. Chemoprevention of lung cancers: lessons from CARET, the beta-carotene and retinol efficacy trial, and prospects for the future. Eur J Cancer Prev 2007;16:184-91.
8. Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005;293:1338-47.
9. Bjelakovic G, Nikolova D, Gluud LL, et al. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2012(3): CD007176.
10. Mares JA, Voland RP, Sondel SA, et al. Healthy lifestyles related to subsequent prevalence of age-related macular degeneration. Arch Ophthalmol 2011;129:470-80.